Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast

被引:1
|
作者
Sharma, Sangeeta Shrestha [1 ]
Sharma, Shishir [1 ]
Zhao, Jie [1 ]
Bureik, Matthias [1 ]
机构
[1] Tianjin Univ, Sch Pharmaceut Sci & Technol, 92 Weijin Rd, Tianjin 300072, Peoples R China
关键词
Cytochrome P450; UDP-glucuronosyltransferase; PROTEIN-PROTEIN INTERACTIONS; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR-CLONING; UGT; 2B7; GENE; P450; GLUCURONIDATION; MODULATION; ISOFORMS;
D O I
10.3390/biomedicines11020281
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochromes P450 (CYPs) and UDP-glucuronosyltransferases (UGTs) are the most important human drug metabolizing enzymes, but their mutual interactions are poorly understood. In this study, we recombinantly co-expressed of each one of the 19 human members of the UGT families 1 and 2 with either CYP2C9, CYP2D6, or CYP4Z1 in fission yeast. Using these strains, we monitored a total of 72 interactions: 57 cases where we tested the influence of UGT co-expression on CYP activity and 15 cases of the opposite approach. In the majority of cases (88%), UGT co-expression had a statistically significant (p < 0.05) effect on P450 activity (58% positive and 30% negative). Strong changes were observed in nine cases, including one case with an activity increase by a factor of 23 (CYP2C9 activity in the presence of UGT2A3) but also four cases with a complete loss of activity. When monitoring the effect of CYP co-expression on the activity of five UGTs, activity changes were generally not so pronounced and, if observed, always detrimental. UGT2B7 activity was not influenced by CYP co-expression, while the other UGTs were affected to varying degrees. These data suggest the notion that mutual influence of CYPs and UGTs on each other's activity is a widespread phenomenon.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes
    Hammons, GJ
    Milton, D
    Stepps, K
    Guengerich, FP
    Tukey, RH
    Kadlubar, FF
    CARCINOGENESIS, 1997, 18 (04) : 851 - 854
  • [42] Inhibitory potential of three Yin-tonification herbal formulas on the activities of human major cytochrome P450 and UDP- glucuronosyltransferases isozymes in vitro
    Jin, Seong Eun
    Shin, Hyeun-Kyoo
    Ha, Hyekyung
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2018, 38 (04) : 511 - 522
  • [43] Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1
    Lu, Danyi
    Ma, Zhiguo
    Zhang, Tianpeng
    Zhang, Xingwang
    Wu, Baojian
    XENOBIOTICA, 2016, 46 (01) : 1 - 13
  • [44] Metabolism of Evodiamine by Human Cytochrome P450 Enzymes
    Fang, Zhong-Ze
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2009, 41 : 99 - 99
  • [45] Oxidation of indole by human cytochrome P450 enzymes
    Guengerich, FP
    Cai, H
    Notley, LM
    DeVoss, JJ
    Gillam, EMJ
    FASEB JOURNAL, 2000, 14 (08): : A1436 - A1436
  • [46] Ipriflavone as an inhibitor of human cytochrome P450 enzymes
    Monostory, K
    Vereczkey, L
    Lévai, F
    Szatmári, I
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (04) : 605 - 610
  • [47] Activation of procarcinogens by human cytochrome P450 enzymes
    Guengerich, FP
    Shimada, T
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 400 (1-2) : 201 - 213
  • [48] INTERACTIONS OF ICLAPRIM WITH HUMAN CYTOCHROME P450 ENZYMES
    Hall, Michael
    Matthews, Anne
    Paul, Danny S.
    Foster, John R.
    Holding, Jeremy D.
    Islam, Khalid
    Brandt, Roger D.
    DRUG METABOLISM REVIEWS, 2007, 39 : 210 - 210
  • [49] Ipriflavone as an inhibitor of human cytochrome P450 enzymes
    Monostory, K
    Vereczkey, L
    FASEB JOURNAL, 1997, 11 (09): : A823 - A823
  • [50] Drug-drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes
    Kanayama, N.
    Kanari, C.
    Masuda, Y.
    Ohmori, S.
    Ooie, T.
    XENOBIOTICA, 2007, 37 (02) : 139 - 154